(Q36920470)

17 August 2017

Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft (English)

1 reference

17 August 2017

1 reference

9

David Sidransky

1 reference

17 August 2017

M Pia Morelli

1

1 reference

17 August 2017

Emiliano Calvo

2

1 reference

17 August 2017

Esther Ordoñez

3

1 reference

17 August 2017

Michael J Wick

4

1 reference

17 August 2017

Belen-Rubio Viqueira

5

1 reference

17 August 2017

Pedro P Lopez-Casas

6

1 reference

17 August 2017

Elizabeth Bruckheimer

7

1 reference

17 August 2017

Antonio Calles-Blanco

8

1 reference

17 August 2017

Manuel Hidalgo

10

1 reference

17 August 2017

language of work or name

English

0 references

publication date

19 December 2011

1 reference

Journal of Clinical Oncology

17 August 2017

1 reference

17 August 2017

30

1 reference

17 August 2017

4

1 reference

17 August 2017

e45-8

1 reference

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Distant metastasis in adenoid cystic carcinoma of salivary origin.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874230

An in vivo platform for translational drug development in pancreatic cancer

4 December 2018

1 reference

12 December 2020

A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands

1 reference

12 December 2020

Management of malignant tumors of the salivary glands

1 reference

12 December 2020

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

1 reference

12 December 2020

Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centre

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2011.36.9678

1 reference

17 August 2017

1 reference

17 August 2017

1 reference